Skip to main content
. 2020 Jan 9;34:174–186. doi: 10.1016/j.molmet.2020.01.003

Figure 7.

Figure 7

GLS expression and its correlation with miR-122 expression in primary human HCCs and poor survival in HCC patients. A. TCGA-LIHC database analysis of GLS and miR-122 expressions in 50 normal liver and 362 primary HCC specimens. B.GLS expression in tumors and normal liver tissues. C.GLS expression levels in HCC with different grades. D. Immunoblot analysis of GLS in human primary HCC (T) and matching benign liver (N) tissues from 5 patients. E. Association of GLS expression with HCC patients' survival in TCGA-LIHC data analyzed using the Cox proportional hazard regression model but displayed with Kaplan–Meier survival curves (p-value is from the test with Cox proportional regression model). F. Correlation between expression of miR-122 and SLC1A5. G. Association of SLC1A5 expression with HCC patients' survival using TCGA-LIHC data (p-value is from the test with Cox proportional regression model). Detailed statistical analysis is provided in Methods.